Dermatol. praxi. 2021;15(4):179-185 | DOI: 10.36290/der.2021.034

Atopic dermatitis of the hands

MUDr. Mirka Martincová, MUDr. Iva Karlová
Klinika chorob kožních a pohlavních, Fakultní nemocnice Olomouc

In this article matter of atopic dermatitis localized on hands is pursued. Typically atopic dermatitis is localized to the flexural surfaces of the body, friction points, but it can also occur on face, legs and hands as mentioned above. It includes etiopathogenesis of AD, differential diagnosis of hand eczema and treatment. The treatment is generally local using topical corticosteroids, external agents with antimicrobial and anti-inflammatory effects and emolients. We can use phototherapy and systematic treatment in some severe cases.

Keywords: atopic dermatitis, eczema, differential diagnosis, treatment.

Published: November 23, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Martincová M, Karlová I. Atopic dermatitis of the hands. Dermatol. praxi. 2021;15(4):179-185. doi: 10.36290/der.2021.034.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bieber T. Atopic dermatitis. N Engl J Med. 2008; 358(14): 1483-1494. Dostupné z: doi: 10.1056/NEJMra074081. PMID: 18385500. Go to original source... Go to PubMed...
    2. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014; 70(2): 338-351. Dostupné z: doi:10.1016/j.jaad.2013.10.010. Go to original source... Go to PubMed...
    3. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015; 66(Suppl) 1: 8-16. Dostupné z: doi: 10.1159/000370220. Go to original source... Go to PubMed...
    4. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016; 387(10023): 1109-1122. Dostupné z: doi: 10.1016/S0140-6736(15)00149-X. Go to original source... Go to PubMed...
    5. Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol. 2014; 150(6): 593-600. Dostupné z: doi: 10.1001/jamadermatol.2013.10271. Go to original source... Go to PubMed...
    6. Flohr C, Mann J. New insights into the epidemiology of childhood atopic dermatitis. Allergy. 2014; 69(1): 3-16. Dostupné z: doi: 10.1111/all.12270. Go to original source... Go to PubMed...
    7. Arenberger P. Dupilumab. Remedia 2018. 28: 570-575. Go to original source... Go to PubMed...
    8. D`Erme AM, Romanelli M, Chiricozzi A. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potencial place in therapy. Drug Design, Development and Therapy 2017; 11: 1473-1480. Go to original source... Go to PubMed...
    9. Karlová I. Dupilumab v léčbě atopického ekzému. In: farmakoterapeutickarevue.cz [online]. [cit. 13-9-2021]. Dostupné z: https://farmakoterapeutickarevue.cz/cs/dupilumab-v-lecbe-atopickeho-ekzemu.
    10. Williams MR, et al. Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis, Science Translational Medicine 2019. doi: 10.1126/scitranslmed.aat8329. Go to original source... Go to PubMed...
    11. Urbánek J. Ekzém rukou. Dermatol. praxi. 2013; 7(1): 11-14.
    12. Kasumagic-Halilovic E, Ovcina-Kurtovic N. Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis. Med Arch. 2018; 72(4): 276-279. Dostupné z: doi: 10.5455/medarh.2018.72.276-279. Go to original source... Go to PubMed...
    13. Miceli A, Schmieder GJ. Palmoplantar Psoriasis. [Updated 2021 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Dostupné z: https://www.ncbi.nlm.nih.gov/books/NBK448142/.
    14. Chamorro MJ, House SA. Tinea Manuum. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Dostupné z: https://www.ncbi.nlm.nih.gov/books/NBK559048/.
    15. Kontaktnî ekzém-dermatitida. DOPORUČENÉ POSTUPY PRO PRAKTICKÉ LÉKAŘE Reg.č.a/004/038.
    16. Viktorinová M. Přehled lokálních kortikosteroidů v dermatologii. Dermatol. praxi. 2010; 4(2): 78-82.
    17. Benáková N. Atopická dermatitida. In: Benáková N, a kol. Moderní farmakoterapie v dermatologii. Maxdorf. 2020: 136-163.
    18. Polášková S. Topické imunomodulátory v léčbě atopické dermatitidy u dětí. Remedia 2009; 19: 41-46.
    19. Ruzicka T, Lynde CW, Jemec GBE, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9- cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br. J. Dermatol. duben 2008; 158(4): 808-881. Go to original source... Go to PubMed...
    20. Diepgen TL, Pfarr E, Zimmermann T. Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: results of the TOCCATA open study comprising 680 patients. Acta Derm. Venereol. květen 2012; 92(3): 251-255. Go to original source... Go to PubMed...
    21. Bissonnette R, Diepgen TL, Elsner P, English J, Graham-Brown R, Homey B, et al. Redefining treatment options in chronic hand eczema (CHE). Journal of the European Academy of Dermatology and Venereology 2010; 24(SUPPL. 3): 1-20. Go to original source... Go to PubMed...
    22. PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004. PubChem Compound Summary for CID 5284373, Cyclosporin A; [cited 2021 Sept. 21]. Dostupné z: https://pubchem.ncbi.nlm.nih.gov/compound/Cyclosporin-A.
    23. Tapia C, Nessel TA, Zito PM. Cyclosporine. [Updated 2020 Dec 1]. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Dostupné z: https://www.ncbi.nlm.nih.gov/books/NBK482450/.
    24. Oosterhaven JAF, Voorberg AN, Romeijn GLE, de Bruin-Weller MS, Schuttelaar MLA. Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study. J Dermatol. 2019; 46(8): 680-685. doi: 10.1111/1346-8138.14982. Epub 2019 Jun 12. PMID: 31187925; PMCID: PMC6771665. Go to original source... Go to PubMed...
    25. Brass D, Fouweather T, Stocken D, et al. An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema. Br J Dermatol. 2018; 179: 63-71. Go to original source... Go to PubMed...
    26. Warner JA, Cruz PD. Grenz ray therapy in the new millennium: Still a valid treatment option? Dermatitis. duben 2008; 19(2): 73-80. Go to original source... Go to PubMed...
    27. Vyšatová M. Klinické projevy atopického ekzému a jeho vliv na výběr budoucího povolání. Lékařské listy 2009; 4: 10-11.
    28. Novotný F. Atopický ekzém. Praha: Triton 2010: 86-87.

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.